212 
A vaginal gel containing Gilead’s AIDS drug cut HIV infections - related to ASX Starpharma play?
A vaginal gel containing Gilead’s AIDS drug cut HIV infections - related to ASX Starpharma play?About the Video
Gilead shares (listed in the US) are up on news that a gel for women was effective in lower the risk of acquiring HIV by 39% (Wall Street Journal report). This study could be related to ASX Starpharma: www.bioinvest.com.au/company/Star pharma/
Terms & Rules
As per ASIC Regulatory Guide 162: All investment tips and comments appearing on this website (Poll results, BLOGS & discussion forums) are submitted by the general public who are not licensed financial advisors. None of the information on this website is financial or investment advice, you should seek independent financial or investment advice by a licensed financial or investment advisor before entering into any position of financial risk. Before using this website, you must agree to the BioInvesting.com.au Terms Of Use